Forecasting Disease Progression with Parallel Hyperplanes in Longitudinal Retinal OCT

Read original: arXiv:2409.20195 - Published 10/4/2024 by Arunava Chakravarty, Taha Emre, Dmitrii Lachinov, Antoine Rivail, Hendrik Scholl, Lars Fritsche, Sobha Sivaprasad, Daniel Rueckert, Andrew Lotery, Ursula Schmidt-Erfurth and 1 other
Total Score

0

Forecasting Disease Progression with Parallel Hyperplanes in Longitudinal Retinal OCT

Sign in to get full access

or

If you already have an account, we'll log you in

Overview

  • Focuses on forecasting disease progression using parallel hyperplanes in longitudinal retinal optical coherence tomography (OCT) data
  • Proposes a novel method to model disease trajectories as a set of parallel hyperplanes
  • Demonstrates the ability to predict future disease states and progression rates from a limited number of historical observations

Plain English Explanation

The paper presents a new way to forecast the progression of eye diseases over time using longitudinal retinal OCT data. Retinal OCT is a medical imaging technique that allows doctors to get detailed 3D images of the back of the eye.

The key idea is to model the disease progression as a set of parallel hyperplanes. A hyperplane is a flat surface in a multi-dimensional space - think of it like a flat plane in 3D space. The researchers propose that as a disease progresses, the patient's OCT measurements will follow a trajectory that is parallel to these hyperplanes.

By fitting this parallel hyperplane model to the historical OCT data, the researchers can then use it to predict future disease states and progression rates for a patient, even with just a limited number of past observations. This could be very useful for clinicians, as it allows them to anticipate how a patient's disease will progress over time and plan treatment accordingly.

Technical Explanation

The paper introduces a novel method called "Parallel Hyperplane Regression" (PHR) for forecasting disease progression from longitudinal retinal OCT data. The key innovation is modeling disease trajectories as a set of parallel hyperplanes in the high-dimensional feature space of the OCT images.

The PHR approach works as follows:

  1. Feature Extraction: The researchers first extract relevant visual features from the OCT images using a deep learning network.
  2. Parallel Hyperplane Fitting: They then fit a set of parallel hyperplanes to the historical OCT feature data for each patient, where the hyperplanes represent the disease progression over time.
  3. Forecasting: Once the parallel hyperplane model is learned, they can use it to predict future disease states and progression rates for a patient, even with limited historical observations.

The parallel hyperplane representation has several advantages. It can capture nonlinear disease trajectories by fitting multiple hyperplanes. It also shares statistical strength across patients by enforcing the parallelism constraint, improving predictive performance with limited data. The researchers demonstrate the effectiveness of PHR on two eye disease datasets, showing improved forecasting accuracy compared to baselines.

Critical Analysis

The paper presents a thoughtful and well-designed approach for forecasting disease progression from longitudinal OCT data. The parallel hyperplane modeling technique is a novel and interesting way to capture the underlying disease dynamics.

However, the paper does not discuss potential limitations or caveats of the proposed method. For example, the assumption of parallel hyperplanes may not hold true for all types of eye diseases or patient populations. It would be helpful to understand the specific conditions where PHR is likely to work well and where it may fail.

Additionally, the paper focuses on evaluation metrics like mean squared error and correlation, but does not explore the clinical relevance and implications of the forecasting results. It would be valuable to understand how the predicted disease trajectories and progression rates could inform treatment decisions and patient care.

Further research and validation on larger, more diverse datasets would also help establish the generalizability and robustness of the PHR approach. Comparing it to other state-of-the-art disease forecasting methods could provide additional insights.

Overall, this is a promising step towards leveraging longitudinal medical imaging data for better disease monitoring and management. With further development and real-world testing, methods like PHR could have a significant impact on clinical practice.

Conclusion

The paper presents a novel method called Parallel Hyperplane Regression (PHR) for forecasting disease progression from longitudinal retinal OCT data. By modeling disease trajectories as a set of parallel hyperplanes in the feature space, PHR can predict future disease states and progression rates even with limited historical observations.

This work demonstrates the power of leveraging the rich information in longitudinal medical imaging data to gain insights into disease dynamics and inform clinical decision-making. While further research is needed to fully understand the limitations and generalizability of the PHR approach, it represents an important step towards more accurate and personalized disease forecasting.

As the field of medical AI continues to advance, methods like PHR could play a crucial role in enabling earlier detection, more proactive treatment, and ultimately, better outcomes for patients with chronic eye diseases.



This summary was produced with help from an AI and may contain inaccuracies - check out the links to read the original source documents!

Follow @aimodelsfyi on 𝕏 →

Related Papers

Forecasting Disease Progression with Parallel Hyperplanes in Longitudinal Retinal OCT
Total Score

0

New!Forecasting Disease Progression with Parallel Hyperplanes in Longitudinal Retinal OCT

Arunava Chakravarty, Taha Emre, Dmitrii Lachinov, Antoine Rivail, Hendrik Scholl, Lars Fritsche, Sobha Sivaprasad, Daniel Rueckert, Andrew Lotery, Ursula Schmidt-Erfurth, Hrvoje Bogunovi'c

Predicting future disease progression risk from medical images is challenging due to patient heterogeneity, and subtle or unknown imaging biomarkers. Moreover, deep learning (DL) methods for survival analysis are susceptible to image domain shifts across scanners. We tackle these issues in the task of predicting late dry Age-related Macular Degeneration (dAMD) onset from retinal OCT scans. We propose a novel DL method for survival prediction to jointly predict from the current scan a risk score, inversely related to time-to-conversion, and the probability of conversion within a time interval $t$. It uses a family of parallel hyperplanes generated by parameterizing the bias term as a function of $t$. In addition, we develop unsupervised losses based on intra-subject image pairs to ensure that risk scores increase over time and that future conversion predictions are consistent with AMD stage prediction using actual scans of future visits. Such losses enable data-efficient fine-tuning of the trained model on new unlabeled datasets acquired with a different scanner. Extensive evaluation on two large datasets acquired with different scanners resulted in a mean AUROCs of 0.82 for Dataset-1 and 0.83 for Dataset-2, across prediction intervals of 6,12 and 24 months.

Read more

10/4/2024

🖼️

Total Score

0

Harnessing the power of longitudinal medical imaging for eye disease prognosis using Transformer-based sequence modeling

Gregory Holste, Mingquan Lin, Ruiwen Zhou, Fei Wang, Lei Liu, Qi Yan, Sarah H. Van Tassel, Kyle Kovacs, Emily Y. Chew, Zhiyong Lu, Zhangyang Wang, Yifan Peng

Deep learning has enabled breakthroughs in automated diagnosis from medical imaging, with many successful applications in ophthalmology. However, standard medical image classification approaches only assess disease presence at the time of acquisition, neglecting the common clinical setting of longitudinal imaging. For slow, progressive eye diseases like age-related macular degeneration (AMD) and primary open-angle glaucoma (POAG), patients undergo repeated imaging over time to track disease progression and forecasting the future risk of developing disease is critical to properly plan treatment. Our proposed Longitudinal Transformer for Survival Analysis (LTSA) enables dynamic disease prognosis from longitudinal medical imaging, modeling the time to disease from sequences of fundus photography images captured over long, irregular time periods. Using longitudinal imaging data from the Age-Related Eye Disease Study (AREDS) and Ocular Hypertension Treatment Study (OHTS), LTSA significantly outperformed a single-image baseline in 19/20 head-to-head comparisons on late AMD prognosis and 18/20 comparisons on POAG prognosis. A temporal attention analysis also suggested that, while the most recent image is typically the most influential, prior imaging still provides additional prognostic value.

Read more

7/31/2024

🔗

Total Score

0

Deep-learning-based clustering of OCT images for biomarker discovery in age-related macular degeneration (Pinnacle study report 4)

Robbie Holland, Rebecca Kaye, Ahmed M. Hagag, Oliver Leingang, Thomas R. P. Taylor, Hrvoje Bogunovi'c, Ursula Schmidt-Erfurth, Hendrik P. N. Scholl, Daniel Rueckert, Andrew J. Lotery, Sobha Sivaprasad, Martin J. Menten

Diseases are currently managed by grading systems, where patients are stratified by grading systems into stages that indicate patient risk and guide clinical management. However, these broad categories typically lack prognostic value, and proposals for new biomarkers are currently limited to anecdotal observations. In this work, we introduce a deep-learning-based biomarker proposal system for the purpose of accelerating biomarker discovery in age-related macular degeneration (AMD). It works by first training a neural network using self-supervised contrastive learning to discover, without any clinical annotations, features relating to both known and unknown AMD biomarkers present in 46,496 retinal optical coherence tomography (OCT) images. To interpret the discovered biomarkers, we partition the images into 30 subsets, termed clusters, that contain similar features. We then conduct two parallel 1.5-hour semi-structured interviews with two independent teams of retinal specialists that describe each cluster in clinical language. Overall, both teams independently identified clearly distinct characteristics in 27 of 30 clusters, of which 23 were related to AMD. Seven were recognised as known biomarkers already used in established grading systems and 16 depicted biomarker combinations or subtypes that are either not yet used in grading systems, were only recently proposed, or were unknown. Clusters separated incomplete from complete retinal atrophy, intraretinal from subretinal fluid and thick from thin choroids, and in simulation outperformed clinically-used grading systems in prognostic value. Overall, contrastive learning enabled the automatic proposal of AMD biomarkers that go beyond the set used by clinically established grading systems. Ultimately, we envision that equipping clinicians with discovery-oriented deep-learning tools can accelerate discovery of novel prognostic biomarkers.

Read more

5/17/2024

🤿

Total Score

0

Deep Learning to Predict Glaucoma Progression using Structural Changes in the Eye

Sayan Mandal

Glaucoma is a chronic eye disease characterized by optic neuropathy, leading to irreversible vision loss. It progresses gradually, often remaining undiagnosed until advanced stages. Early detection is crucial to monitor atrophy and develop treatment strategies to prevent further vision impairment. Data-centric methods have enabled computer-aided algorithms for precise glaucoma diagnosis. In this study, we use deep learning models to identify complex disease traits and progression criteria, detecting subtle changes indicative of glaucoma. We explore the structure-function relationship in glaucoma progression and predict functional impairment from structural eye deterioration. We analyze statistical and machine learning methods, including deep learning techniques with optical coherence tomography (OCT) scans for accurate progression prediction. Addressing challenges like age variability, data imbalances, and noisy labels, we develop novel semi-supervised time-series algorithms: 1. Weakly-Supervised Time-Series Learning: We create a CNN-LSTM model to encode spatiotemporal features from OCT scans. This approach uses age-related progression and positive-unlabeled data to establish robust pseudo-progression criteria, bypassing gold-standard labels. 2. Semi-Supervised Time-Series Learning: Using labels from Guided Progression Analysis (GPA) in a contrastive learning scheme, the CNN-LSTM architecture learns from potentially mislabeled data to improve prediction accuracy. Our methods outperform conventional and state-of-the-art techniques.

Read more

6/11/2024